We describe a method for the collection and microanalysis of the volatile organic compounds in human breath. A transportable apparatus supplies subjects with purified air and samples their alveolar breath; the volatile organic compounds are captured in an adsorptive trap containing activated carbon and molecular sieve. The sample is thermally desorbed from the trap in an automated microprocessor-controlled device, concentrated by two-stage cryofocusing, and assayed by gas chromatography with ion-trap detection. Compounds are identified by reference to a computer-based library of mass spectra with subtraction of the background components present in the inspired air. We used this device to study 10 normal subjects and determined the relative abundance of the volatile organic compounds in their alveolar breath. The breath-collecting apparatus was convenient to operate and was well tolerated by human volunteers. 
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Breath analysis has attracted scientific attention for more than 200 years: Lavoisier and Laplace analyzed the breath of a guinea pig in 1784, demonstrating that respiration and combustion were analogous processes (1). More recently, sensitive analyses have demonstrated several volatile organic compounds in normal human breath, many of which have been identified by gas chromatography (GC) combined with mass spectroscopy (MS) (2) (3) (4) .
Microanalysis
for volatile organic compounds in the breath yields information about the pool of low-molecular mass compounds in the blood that diffuse across the pulmonary alveolar membrane. These compounds originate from two major sources: endogenous (i.e., products of metabolism) or exogenous (i.e., derived from outside the body). Consequently, breath analysis potentially presents a unique window on human metabolism, and simultaneously detects exposure to volatile organic toxins in the environment, without incurring the discomfort or inconvenience of collection of body fluid. Although GCI #{149} Although a wide variety of assays have been described for human breath, each has its own particular advantages and disadvantages. Breath contains a complex mixture of volatile organic compounds, and the selection of a GC column usually represents a compromise in which some compounds are separated better than others (e.g., nonpolar compounds might be better resolved than polar compounds). The selection of a detector may also represent a compromise: flame ionization detects several of the compounds in the breath (9) but is not sensitive to the sulfur-containing compounds, which are better detected by flame photometry (10,11). 
#{149}
The desorption and transfer of the concentrated sample from the trap to the assay instrument must be performed with minimal loss or contamination. In several methods described this was accomplished ad hoc by structural linkages between the trap and the CC inlet port. This step has now been considerably simplified by the commercial availability of microprocessor-controlled thermal desorbers that elute, concentrate, and inject the sample in a standardized fashion (13, 14) . #{149} Because room air frequently contains many volatile organic compounds, it may be difficult to distinguish the alveolar breath signal from the environmental background. In practice, this is not a significant problem for an endogenous compound that is present in comparatively high concentrations in the breath (e.g., isoprene).
However, when a compound is present in both the alveolar breath and the inspired air, background contamination must be taken into account. One approach to this problem is to supply the subject with a source of purified air to inspire during the breath collection, to determine which of the volatile organic compounds observed in the sample were derived from the lungs.
This brief list is not intended as a comprehensive review, but should serve to illustrate the major difficulties associated with the collection, concentration, and microassay of the volatile organic compounds in alveolar breath. This report describes a technique to minimize these problems, evolved from methods previously described by the authors (14-16) and others (12,13,17). We describe a portable breath-collecting apparatus that is capable of trapping a water-free sample of alveolar breath without discomfort to the donor. Samples are thermally desorbed, concentrated by two-stage cryofocusing, then assayed by CC/MS with an ion-trap detector.
Materials and Methods

Breath CollectionApparatus
The device, whose mechanism is shown schematically in Figure  1 , is transportable on a hand-propelled wheeled cart, and incorporates the following components.
Purified air source. Room air pumped through a metal 
Respirometer.
Used to monitor the respiratory minute volume and the flow of purified air (with occlusion of the mouthpiece and the upstream exhaust tube). We used a Wright respirometer (Herman Berman, Van Nuys, CA).
Breath CollectionMethod
Samples were collected between 0700 and 1100 h, after an overnight fast. Each subject wore a nose clip and was instructed to breathe in and out through the mouth, which was closely applied around the mouthpiece to form a seal. The apparatus was positioned so that the mouthpiece was angled slightly upward, ensuring that saliva did not flow into it. The subject breathed into the device for 10 miii. After the subject had breathed purified air for 3.0 mm (to purge the lungs of room air), we started the pump. Breath was sampled at 2.0 L/min for 2.0 miii with the three-way tap adjusted to bypass the trap to purge the collecting apparatus. The flow was then switched to the adsorptive trap for 5.0 mm, so that a total of 10.0 L of breath was sampled. We then removed the trap from the apparatus and stored it in a hermetically sealed container until the assay. A background sample of purified air was collected in a similar fashion at the time of each breath collection.
The breath passing through the adsorptive trap comprised alveolar air with very little contamination by dead-space air. A resting normal subject discharged, on average, 500 mL of breath into the apparatus with each expiration. The downstream exhaust tube confined this sample to a column containing 150 mL of dead-space air followed by a 350-mL column of alveolar air (18) . The column of alveolar air was sampled continuously except for a brief period at the beginning of each expiration when the column of dead-space air passed through T-tube 2. Breath was extracted from T-tube 2 at a rate of 2.0 L/min (33 mLIs); to totally deplete the 350-mL column of alveolar air in the reservoir tube would have required a sampling period >10.6 s. This could have occurred only in a subject respiring at fewer than six times a minute, which we did not observe in normal resting individuals.
Procedures
Sample desorption and concentration. This method has been described elsewhere (14) . In summary, the sample is desorbed from the adsorptive trap, then concentrated by two-stage cryofocusing with a microprocessor-controlled thermal desorber (5010 GT automatic on-line desorber; Tekmar). The adsorptive trap is flushed with helium (10 mL/mun), first at room temperature for 5 mm to remove any water, and then at 280 #{176}C for 8 mm. The liberated volatile compounds are first captured in an internal cryogenic trap (at -150 #{176}C), then volatilized at 250 #{176}C and captured again in an external cryogenic trap (at -150 #{176}C) mounted on the inlet port of a gas chromatograph. The external cryogenic trap is then heated to 200 #{176}C and the concentrated volatilized sample is injected into the column of the gas chromatograph. Initially, we encountered difficulty during thermal desorption of a sample from a trap, when the flow rate of helium intermittently decreased after 2-4 mm of heating. Installation of a replacement cryotrap with a wider bore (6.3 mm diameter) completely resolved this problem.
GC/MS assay of volatile compounds. We used a gas chromatograph with subambient temperature programming capability (Model HP5890A; Hewlett-Packard, Avondale, PA). After the splitless injection of the sample from the external cryogenic trap, the oven temperature was held at 0#{176}C for 10 Relative abundance was determined only for those compounds with a greater concentration in alveolar breath than in the inspired background air. This calculation of relative abundance should be regarded as only a first approximation, given the improbability that the ion-trap responded with similar intensity to equimolar quantities of all of the compounds observed.
ClinicalStudy
Ten fasting normal volunteers were studied; all subjects gave their signed informed consent to participate in this research, which was approved by the Samples were collected and assayed as described above, and the relative abundance of the observed compounds was determined. The group mean (and SD) of the relative abundance of all volatile compounds in the breath was determined, so that compounds could be ranked from most to least abundant.
Results and DIscussion
No subject experienced any discomfort during a breath collection, after the position of water trap 1 had been modified as described above. shown in Table 1 . The results from the 10 normal subjects were pooled, and the relative abundance of alveolar breath compounds (following background subtraction) is shown in Table 2 .
The transportable apparatus permitted the collection of breath samples without inconvenience to the user or discomfort to the donor. In addition, the assay demonstrated the efficacy of ion-trap detection for the characterization of volatile organic compoundsin concentrated alveolar breath.
This study also demonstrated differences between the chromatograms of alveolar breath and the inhaled purified air. By subtracting the "background moise" from the chromatograms of alveolar breath, we could identiir the "breath signal," i.e., those compounds derived exclusively from the lungs. Our findings suggest that future studies of volatile organic compounds in the breath should pay close attention to the potential sources of any observed compound: the lungs, the inhaled air, or contamination during collection or assay of the sample. The compounds listed in Table 2 1,2-Dimethylpropylcyclohexane a The "background" components of purified air were subtracted from the chromatogram of alveolar breath,andcompounds were chemically Identified on the basis of the best observed match between the mass spectrum generated in the Ion-trap detector and the mass spectra in a computer-based libraty.
curve as well as the determination of the precision and accuracy of the assay for every compound observed.
Because several other methods have been described for the collection and analysis of human breath, we emphasize how this method represents an advance: First, the breath collection apparatus was assembled from standard "off the shelf' components, and did not require specialized resources for its construction. The apparatus was transportable and convenient to use at sites remote from the laboratory (e.g., at a patient's bedside in a hospital). Moreover, the apparatus was highly acceptable to patients, including those who were severely ill. Resistance to expiration was minimal, so that little effort was required to breathe into the apparatus for 10 min for collection of a sample. The process of collecting a sample by resin adsorption followed by 
0.01
More compounds are shown here than In Table 1 , because the results are a composite of 10 separate studies, and not all compoundswere detected in every subject. This ranking should be regarded only as a firstapproximation. because It is based on the assumption that the ion-trapdetector responded with equal sensitivity to equimolar quantities of all the compounds tested.
quirement for the assay of breath by GC/MS. Assay by ion-trap detection facilitated highly sensitive and specific identification of volatile organic compounds. Finally, by supplying purified air to the subject and subtracting the inhaled "background noise," we could distinguish the endogemous components of alveolar breath from exogenous artefacts of the assay. This approach, which has not been previously described to our knowledge, provides a uniquely sensitive method for distinguishing signal from noise in the microanalysis of breath.
Exogenous volatile organic compounds largely originate from indoor and outdoor pollution of the air, though some may be naturally occurring products of biological processes in plants, animals, and microorganisms. For only a small number of endogenous volatile organic compounds is the biological source known; for example, endogenous ethanol may originate from barterial fermentation in the large intestine as well as from hepatic reduction of endogenous acetaldehyde (15) . This assay provides a convenient method of distinguishing the two kinds of sources, because endogenous compounds should be present in higher concentrations in breath than in environmental air.
In conclusion, potential applications of this new assay include the following: It provides a method of distinguishing endogenous from exogenous compounds in the breath, so that environmental pollutants might be identified and their biological effects quantified. It provides a uniquely sensitive window on human metabolism of volatile organic compounds, and a tool for investigating metabolic pathways for which the significance is still unknown.
Finally, it may provide a new tool for the diagnosis of disease. Although still in the investigational stage, the analysis of volatile organic compounds in the breath apparently can provide a noninvasive diagnostic test for the early detection of a wide variety of diseases, including cirrhosis of the liver (10, 11), rheumatoid arthritis (19) , lung cancer (20) , schizophrenia (21, 22) , and acute myocardial infarction (23) .
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